Related Experiment Video

Updated: Dec 22, 2025

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.6K

[MS update: risk factors, diagnosis and treatment]

Haukur Hjaltason1, Olafur Sveinsson1

  • 1Department of Neurology, National University Hospital, Reykjavik, Iceland, Faculty of Medicine, University of Iceland.

Laeknabladid
|May 6, 2020
PubMed

Insights

Multiple sclerosis (MS) is a common central nervous system inflammatory disease. Recent advances improve understanding of MS risk factors, diagnosis, and treatment, emphasizing early detection and management for neurological disability.

Area of Science:

  • Neurology
  • Immunology
  • Genetics

Background:

  • Multiple sclerosis (MS) is the leading chronic inflammatory disease of the central nervous system.
  • It is a primary cause of neurological disability in young and middle-aged adults.
  • MS is an autoimmune condition influenced by genetic and environmental interactions.

Purpose of the Study:

  • To review recent advancements in understanding the etiology of MS.
  • To discuss improvements in the diagnosis of MS.
  • To highlight new therapeutic strategies for managing MS.

Main Methods:

  • Literature review of recent research on MS.
  • Synthesis of current knowledge on MS risk factors.
  • Analysis of diagnostic criteria and treatment efficacy.

Main Results:

  • Significant progress has been made in identifying MS risk factors.
  • Diagnostic capabilities for MS have dramatically improved.
  • Treatment options for MS have seen substantial advancements.

Conclusions:

  • Early diagnosis and effective treatment are crucial for managing MS.
  • Awareness of new knowledge is vital for healthcare professionals.
  • Continued research is essential for further improving patient outcomes in MS.
Keywords:
Multiple sclerosisdiagnosisprogressionrelapsetreatment

More Related Videos

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.3K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.8K

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
1.3K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.6K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.8K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
687
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.6K
Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
814